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Studies of both complement activation and PMN cyclic nu-
cleotide levels are needed to characterize these systemic mani-
festations of psoriasis. 
The authors thank Drs. G. Pearson and J. Hall for their aid in 
obtaining the lithium-treated patients, Drs. J. Wayne Streilein and 
James N. Gilliam for their helpful advice, and Ms. Marquita Brown for 
excellent secretarial assistance. 
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Statement of Committee for Dermatopathology 
·The Committee for Dermatopathology, with full concurrence of The American Board of Dermatology 
and The American Board of Pathology, announces a change in one of the prerequisites for qualification 
for the examination for special competence in dermatopathology based on experience in dermatopathol-
ogy. The Dermatopathology Credentials Committee will consider applications from persons who hold a 
basic certificate from The American Board of Dermatology or The American Board of Pathology 
(anatomic pathology, or anatomic and clinical pathology) and 2 yr of experience in dermatopf!.thology 
acceptable to the Committee for Dermatopathology. The training requirements for basic certification 
must have been completed before December 31, 1977, and the 2 yr of acceptable experience in dermato-
pathology must have been completed before December 31, 1979. The final expiration date for applications 
under this prerequisite is December 31, 1981. Other qualifications to take the dermatopathology exami-
nation remain as stated in the Requirements for Certification in the Directory of Residency Training 
Programs. Persons who believe they may qualify for the special competence examination in dermato-
pathology as a result of this change should request an application form from the office of either The 
American Board of Dermatology or The American Board of Pathology. 
